Viewing nowDongkwang Rosuvastatin Calcium Tablet 5mg
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201702789 · Approved 2017.05.31 · Insurance code 645906290
Treatment of dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease
This medicine is mainly used as an adjunct therapy in patients with primary hypercholesterolemia, mixed dyslipidemia, and dysbetalipoproteinemia when dietary changes and exercise are insufficient. It is also effective in patients with homozygous familial hypercholesterolemia and specific pediatric patients aged between 10 and 17 years with familial hypercholesterolemia. This drug helps to lower total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis and reducing the risk of cardiovascular diseases such as stroke and myocardial infarction. It is particularly recommended for men over 50 years of age and women over 60 years of age with elevated high-sensitivity C-reactive protein levels and additional risk factors. In summary, this drug is used to lower the risk of hypercholesterolemia and related cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed when the Child-Pugh score was 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medicine should not be used in certain patients. For example, it should not be administered to patients allergic to this drug, patients with severe liver dysfunction, patients with muscle disorders, patients with severely impaired kidney function, and pregnant or breastfeeding women. Additionally, women who may become pregnant must use appropriate contraception while taking this drug and should discontinue use immediately if they become pregnant. This drug can affect the liver and muscles; therefore, patients with a history of liver disease or those who consume alcohol excessively should have their liver function tested before administration and regularly during treatment. If symptoms such as muscle pain or weakness occur, notify healthcare professionals immediately and if necessary, check for abnormalities with muscle enzyme tests. This drug may interact with other medications, so it is essential to inform healthcare professionals if taking other medications, especially when using specific antibiotics, immunosuppressants, antiviral drugs, or fibrate-type drugs. During the intake of this drug, it is possible to experience abnormal symptoms such as liver dysfunction, muscle abnormalities, or allergic reactions; therefore, consult a professional if such symptoms arise. There is no specific antidote for overdose; thus, one should seek proper treatment and examination at a hospital promptly, and although this drug has minimal effects on driving ability or machinery operation, caution is advised due to potential dizziness. Finally, this drug may result in higher blood concentrations in Asians, indicating that dosage adjustments may be necessary.
Angioedema, hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is recommended to store the drug at room temperature between 1°C and 30°C. Avoid placing it in excessively hot or cold areas, and store it away from direct sunlight.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 30 tablets/box [(10 tablets/PTP)×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.